OMICS Group: Advertising conferences to spamtraps

This post is Part 2 in a series of two. OMICS Group are not content to spam through an ESP; they’re also spamming under bioprovider.com, a Domain by Proxy.

Spamming IP: 216.40.218.178

Spam headers:

Return-Path: <omx@lifescienceshome.com>
Received: from server1 (server1.bioprovider.com [216.40.218.178])
        by x (Postfix) with SMTP id x
        for <x>; Tue, 20 Mar 2012 11:4x:xx +0200 (EET)
Received: from server1[127.0.0.1] by server1[127.0.0.1]
        (SMTPD32); Tue, 20 Mar 2012 04:4x:xx -0500
Reply-To: omx@lifescienceshome.com
Message-ID: <x@lifescienceshome.com>
From: Omics Evolution Summit 2012 <omx@lifescienceshome.com>
To: x
Subject: George Church to Keynote at the Omics Evolution Summit 2012
Date: Tue, 20 Mar 2012 04:4x:xx -0500
MIME-Version: 1.0
Content-Type: text/html;
        charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable

Human-readable spam content: None, the message does not have a text/plain part. Here’s the HTML:

If
you can’t view this page, please visit: http://www.gtcbio.com/newsletter/OMXI-w.htm 
x

George Church, Director of the Center
for Computational Genetics at Harvard Medical School, to give Plenary
Keynote Presentation at the Omics Evolution Summit in Boston, MA, May
29-31, 2012

Register
and save up to $500 before the 20% discount ends on March
30th.


Dear Colleague,

George Church, Professor of Genetics and Director of the Center
for Computational Genetics at Harvard Medical School will be giving a
plenary keynote presentation entitled “The Personal Genome Project –
Open Access to Genome Sequences + Trait Data
” at the Omics
Evolution Summit
to be held on May 29-31, 2012 at the Hyatt
Harborside Hotel in Boston, MA.

The Personal Genome Project
enables open observation and critique of a large cohort “test-driving”
comprehensive participatory personalized medicine. Since 2004, George
Church and his team have helped push the cost of reading and writing DNA
(and biological systems) down by a million-fold (5-fold faster exponential
than Moore’s law) and enabled fully open-access human
Genome+Environment=Trait (GET) data, stem cells, and clinical community
curation / interpretation tools (Evidence.PersonalGenomes.org).

Dr.
Church will be speaking in the Plenary Keynote Session of the Omics
Evolution Summit
. Other keynote speakers in the session include
Craig C Mello, Ph.D., Distinguished Professor of Molecular Medicine and
Nobel Laureate, at the University of Massachusetts Medical School and
HHMI, and Steven Burrill, CEO of Burrill & Company.

The Omics
Evolution Summit
will bring together leading pharmaceutical and
diagnostic companies, top scientists and government experts to discuss
research and developments in drug discovery, new technologies and the
evolving landscape of the industry in genomics, proteomics, RNAi,
next-generation sequencing, epigenetics and protein kinases.

The
Summit will have six tracks that will allow attendees to engage in
individual programs – or portions of all tracks – while enjoying
networking opportunities with all attendees, speakers, poster presenters
and exhibitors:

2nd
Genomic & Proteomic Drug Discovery

2nd
Next Generation Sequencing

2nd
Epigenetics in Drug Discovery

3rd
RNAi Research and Development

7th
Protein Kinases in Drug Discovery

Genome-wide
Partnering & Dealmaking

In
addition, there is a Pre-Summit Clincal
Sequencing Workshop
on May 29th that will present an overview of
sequencing product profiles and technical underpinnings as well as discuss
from a user’s perspective the many issues of the implementation of
Next-Generation Sequencing into the clinical space.

Sign
up
today to save 20% off the regular price before March
30th
!
Or bring your team with a Register
2, the 3rd person goes free discount! Use discount code
rcdvb.


KEYNOTE
AND FEATURED SPEAKERS


George Church, Ph.D.,
Professor of Genetics, Director of the Center for Computational Genetics,
Harvard Medical School

Rade Drmanac, Chief Scientific
Officer, Complete Genomics

Nathanael S. Gray, Ph.D.,
Professor, Biological Chemistry and Molecular Pharmacology, Dana Farber
Cancer Institute, Harvard Medical School

Alexander Meissner,
Ph.D., Assistant Professor, Harvard University, Senior Associate Member,
the Broad Institute of MIT and Harvard

Craig C. Mello,
Ph.D., Distinguished Professor, Molecular Medicine, Nobel Laureate,
University of Massachusetts Medical School; HHMI

Rachel
Meyers, Ph.D., Vice President, Research and RLD, Alnylam

Rab
Prinjha, Interim Head of Epinova Epigenetics DPU, Head of Biology,
GlaxoSmithKline, UK

John Quackenbush, Professor,
Computational Biology and Bioinformatics, Dana-Farber Cancer
Institute

John J. Rossi, Ph.D., Lidow Family Endowed Professor
and Chairman, Molecular and Cellular Biology, Beckman Research Institute,
City of Hope

Matthew Stanton, Ph.D., Head, RNA Optimization,
Merck

Richard M. Weinshilboum, Mary Lou and John H. Dasburg
Professor, Cancer Genomics Research; Chair, Division of Clinical
Pharmacology; Professor Molecular Pharmacology & Experimental
Therapeutics and Medicine, Mayo Clinic College of
Medicine

Michael B. Yaffe, Ph.D., Professor, Biology and
Biological Engineering, Massachusetts Institute of
Technology

Steven Burrill, Chief Executive Officer, Burrill &
Company

For a complete speaker list, click
here
.


Click the Conference title to view the agenda of each
track:


Clinical
Sequencing Workshop

2nd
Genomic & Proteomic Drug Discovery

2nd
Next Generation Sequencing

2nd
Epigenetics in Drug Discovery

3rd
RNAi Research and Development

7th
Protein Kinases in Drug Discovery

Genome-wide
Partnering & Dealmaking

Sign
up
to attend the Clinical
Sequencing Workshop
on May 29th.
And register
for the Omics
Evolution Summit
to get access to all 6 tracks!

 


For
Business Development & Exhibiting Opportunities contact Maribel
Cortes,
spex@gtcbio.com

UPCOMING
CONFERENCES

2nd
Annual Diabetes Summit

Apr. 19-20, 2012, Boston, MA
10% discount by Mar. 19th

5th
Diabetes Drug Discovery and Development

Apr. 19-20, 2012,
Boston, MA
10% discount by Mar.
19th

2nd
Diabetes Partnering and Deal-making

Apr. 19-20, 2012, Boston,
MA
10% discount by Mar.
19th

Healthcare
Centers of Excellence Pre-Summit Workshop

May 15, 2012,
Atlanta, GA
10% discount by Apr. 15th

Healthcare
Centers of Excellence Summit

May 15-17, 2012, Atlanta,
GA
10% discount by Apr. 15th

Cancer
Centers of Excellence Meeting

May 15-17, 2012, Atlanta,
GA
10% discount by Apr. 15th

Diabetes
Centers of Excellence Meeting

May 15-17, 2012, Atlanta,
GA
10% discount by Apr. 15th

Cardiac
Centers of Excellence Meeting

May 15-17, 2012, Atlanta,
GA
10% discount by Apr.
15th

2nd Infectious Diseases World Summit
July
9-10, 2012, San Francisco, CA

10th
Vaccines Research & Development: All Things Considered

July
9-10, 2012, San Francisco, CA
20% discount by May.
9th

9th
Anti-Infectives Partnering & Deal-making

July 9-10, 2012,
San Francisco, CA
20% discount by May.
9th

Influenza Research & Development
July
9-10, 2012, San Francisco, CA

 

8th
Stem Cell Summit

Apr. 19-20, 2012, Boston, MA
10% discount by Mar. 19th

8th
Stem Cell Research and Regenerative Medicine

Apr. 19-20, 2012,
Boston, MA
10% discount by Mar.
19th

Stem
Cell Commercialization & Partnerin
g

Apr. 19-20, 2012,
Boston, MA
10% discount by Mar.
19th

Drug Discovery and Regulatory Summit
June
7-8, 2012, San Diego, CA

6th
Drug Design and Medicinal Chemistry

June 7-8, 2012, San Diego,
CA
20% discount by Apr. 7th

Antibody
Design and Drug Discovery

June 7-8, 2012, San Diego,
CA
20% discount by Apr. 7th

Life
Science Legal & Business Strategy

June 7-8, 2012, San
Diego, CA
20% discount by Apr.
7th

Biospecimens and Biorepositories
June 7-8,
2012, San Diego, CA

2nd Biomarker Europe
Summit

September, 2012
Zurich, Switzerland

This
advertisement is sent to x from GTC, 434 W. Foothill Blvd,
Monrovia, CA 91016. If you prefer not to receive further messages from
this sender, please forward this email to remove@gtcbio.com or use the following link to
unsubscribe http://gtcbio.com/unsubscribe.php?emailid=x

One Response to OMICS Group: Advertising conferences to spamtraps

  1. Pingback: OMICS Group: Asking spamtraps to submit papers » MainSleaze

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Go back to top